<bill session="117" type="h" number="6216" updated="2023-04-26T13:00:25Z">
  <state datetime="2021-12-09">REFERRED</state>
  <status>
    <introduced datetime="2021-12-09"/>
  </status>
  <introduced datetime="2021-12-09"/>
  <titles>
    <title type="display">Sickle Cell Disease Comprehensive Care Act</title>
    <title type="short" as="introduced">Sickle Cell Disease Comprehensive Care Act</title>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to establish a demonstration project to improve outpatient clinical care for individuals with sickle cell disease.</title>
  </titles>
  <sponsor bioguide_id="D000096"/>
  <cosponsors>
    <cosponsor bioguide_id="A000370" joined="2022-05-13"/>
    <cosponsor bioguide_id="A000371" joined="2022-05-13"/>
    <cosponsor bioguide_id="B001270" joined="2022-02-02"/>
    <cosponsor bioguide_id="B000490" joined="2022-02-02"/>
    <cosponsor bioguide_id="B001248" joined="2021-12-09"/>
    <cosponsor bioguide_id="C001072" joined="2022-02-02"/>
    <cosponsor bioguide_id="C001067" joined="2022-02-02"/>
    <cosponsor bioguide_id="D000630" joined="2022-02-02"/>
    <cosponsor bioguide_id="F000454" joined="2022-08-12"/>
    <cosponsor bioguide_id="L000586" joined="2022-05-13"/>
    <cosponsor bioguide_id="L000551" joined="2022-02-02"/>
    <cosponsor bioguide_id="M001160" joined="2022-02-02"/>
    <cosponsor bioguide_id="N000147" joined="2022-02-02"/>
    <cosponsor bioguide_id="R000486" joined="2022-02-02"/>
    <cosponsor bioguide_id="R000515" joined="2022-02-03"/>
    <cosponsor bioguide_id="S001185" joined="2022-02-02"/>
    <cosponsor bioguide_id="T000481" joined="2022-02-02"/>
  </cosponsors>
  <actions>
    <action datetime="2021-12-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-12-09" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-12-10">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="s" number="3389" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Blood and blood diseases"/>
    <term name="Congressional oversight"/>
    <term name="Government information and archives"/>
    <term name="Health care coverage and access"/>
    <term name="Health information and medical records"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Hereditary and development disorders"/>
    <term name="Home and outpatient care"/>
    <term name="Intergovernmental relations"/>
    <term name="Medicaid"/>
    <term name="Minority health"/>
  </subjects>
  <amendments/>
  <summary date="2022-04-19T22:21:57Z" status="Introduced in House">Sickle Cell Disease Comprehensive Care Act

This bill establishes and provides funds for a demonstration project for state Medicaid programs to improve outpatient care for individuals with sickle cell disease, with a focus on young adults and pregnant women.

The Centers for Medicare &amp; Medicaid Services must award planning grants to at least 10 states and must select between 5 and 10 states to participate in the project. Participating states must provide specified services and support for individuals with sickle cell disease, including multidisciplinary care teams, appropriate treatments, mental health services, and specialist services.

The bill provides a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for services provided through the project.</summary>
</bill>
